Clinical Trials on B-CLL in China
总计34643个结果
-
First Affiliated Hospital of Zhejiang University未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Shenzhen BinDeBio Ltd.Children's Hospital of Fudan University主动,不招人复发性 B 细胞急性淋巴细胞白血病,童年 | 难治性 B 细胞急性淋巴细胞白血病,儿童 | 复发/难治性 B 细胞淋巴瘤,童年中国
-
The First Affiliated Hospital with Nanjing Medical...Guangzhou Lupeng Pharmaceutical Company LTD.; Newave Pharmaceutical Inc招聘中
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial Hospital尚未招聘
-
Antengene Corporation主动,不招人
-
Yan'an Affiliated Hospital of Kunming Medical University招聘中
-
Yan'an Affiliated Hospital of Kunming Medical UniversityKAEDI未知
-
Wuhan Union Hospital, ChinaCSPC Pharmaceutical Group Limited招聘中
-
Shanghai Ming Ju Biotechnology Co., Ltd.尚未招聘
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.未知
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & Institute招聘中
-
Hoffmann-La Roche完全的
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical University; Beijing Jingdu Children's Hospital招聘中
-
Shenzhen BinDeBio Ltd.Xiangya Hospital of Central South University招聘中复发性 B 细胞急性淋巴细胞白血病,童年 | 难治性 B 细胞急性淋巴细胞白血病,儿童 | 复发/难治性 B 细胞淋巴瘤,童年中国
-
Shanghai Ming Ju Biotechnology Co., Ltd.尚未招聘淋巴瘤,大 B 细胞,弥漫性 | 高级别 B 细胞淋巴瘤 | 滤泡性淋巴瘤 3B 级 | 纵隔 B 细胞弥漫性大细胞淋巴瘤中国
-
The Affiliated Hospital of Xuzhou Medical University招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Hebei Yanda Ludaopei HospitalGracell Biotechnology Ltd.未知
-
Han weidong招聘中复发难治性 B 细胞非霍奇金淋巴瘤 | Decitabine 引发的串联 CD19/CD20 CAR T 细胞中国
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
920th Hospital of Joint Logistics Support Force...Gracell Biotechnology Shanghai Co., Ltd.; Kunming Hope of Health Hospital招聘中
-
The First Affiliated Hospital with Nanjing Medical...未知淋巴瘤,B细胞 | 白血病,B细胞中国
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University Cancer...招聘中年龄范围≥16岁,性别不限 | 组织病理学证实弥漫性大 B 细胞淋巴瘤或高级别 B 细胞淋巴瘤 | 先前接受过 DLBCL 或 HGBL 的一线化疗,四个周期未能达到 CR,或复发 | 根据 2014 年霍奇金和非霍奇金淋巴瘤卢加诺标准至少有一个阳性病变 | ECOG 身体状况评分为 0-3 | 研究人员判断预期寿命至少为三个月 | 了解并自愿签署书面知情同意书中国
-
Peking Union Medical College HospitalCellular Biomedicine Group Ltd.完全的
-
Cothera Bioscience, Inc招聘中淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴系统疾病 | 伯基特淋巴瘤 | 高级别 B 细胞淋巴瘤 | C-MYC/BCL6 双重打击高级别 B 细胞淋巴瘤 | C-MYC/BCL2 双重打击高级别 B 细胞淋巴瘤 | 淋巴瘤,高级 | C-Myc基因重排大韩民国, 中国
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Rongu Biotechnology Co., Ltd.招聘中
-
Novartis Pharmaceuticals主动,不招人
-
Beijing InnoCare Pharma Tech Co., Ltd.招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Guangzhou Lupeng Pharmaceutical Company LTD.招聘中
-
Xuzhou Medical University招聘中